STAANasdaqOphthalmic GoodsFiscal year ends January 2
STAAR SURGICAL CO
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Aug 12, 2026
$21.88+0.61 (+2.87%)
Close on Oct 19, 2026
- Market cap
- $1.13B
- P/E (TTM)
- 312.6
- Dividend yield
- –
Share price
−$3.15 (−12.58%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
STAAR SURGICAL CO grew revenue 51.3% to $339.59M over the twelve months to Jul 3, 2026. Free cash flow was -$6.75M.
Revenue
$339.59M
+51.3% vs. a year earlier
Operating income
$13.73M
TTM Q2 2026
Free cash flow
-$6.75M
TTM Q2 2026
EPS, diluted
$0.07
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jul 3, 2026
Valuation
- Market cap
- $1.13B
- P/E ratio
- 312.6
- Price to sales
- 3.32
- Price to book
- 3.08
- Dividend yield
- –
- Free cash flow yield
- -0.60%
Fundamentals
- Revenue
- $339.59M
- Net income
- $3.84M
- EPS, diluted
- $0.07
- Free cash flow
- -$6.75M
- Book value per share
- $7.09
- Diluted shares
- 52M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$339.59M+51.3% YoY
Gross profit
$260.20M+61.7% YoY
Operating income
$13.73M
Net income
$3.84M
EPS, diluted
$0.07
Free cash flow
-$6.75M
Reported periodTrailing twelve months